These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15133632)

  • 1. Strategies for immune therapy: Würzburg, Germany, 29 February-3 March 2004.
    Pawelec G; Gouttefangeas C
    Cancer Immunol Immunother; 2004 Aug; 53(8):755-8. PubMed ID: 15133632
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor immunology top 10 list.
    Finn OJ
    Immunol Rev; 2008 Apr; 222():5-8. PubMed ID: 18363991
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunology and immunotherapy of human cancer: present concepts and clinical developments.
    Bremers AJ; Parmiani G
    Crit Rev Oncol Hematol; 2000 Apr; 34(1):1-25. PubMed ID: 10781746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment.
    Gjerstorff MF; Burns J; Ditzel HJ
    Expert Opin Biol Ther; 2010 Jul; 10(7):1061-75. PubMed ID: 20420535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward next-generation cancer immunotherapy: 10th annual meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 23-25, 2012.
    Kloke BP; Kutscher S; Rae R; Kvistborg P; Britten CM; Hadrup SR
    Cancer Immunol Immunother; 2013 May; 62(5):975-81. PubMed ID: 23299564
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular Targets in Cancer Therapy - Fourth Biennial Meeting. Mechanism and therapeutic reversal of immune suppression in cancer.
    Herber DL
    IDrugs; 2007 Apr; 10(4):227-9. PubMed ID: 17390239
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer vaccines: pessimism in check.
    Mocellin S; Mandruzzato S; Bronte V; Marincola FM
    Nat Med; 2004 Dec; 10(12):1278-9; author reply 1279-80. PubMed ID: 15580242
    [No Abstract]   [Full Text] [Related]  

  • 8. Preface: More than two decades of modern tumor immunology.
    Galluzzi L; Rudqvist NP
    Methods Enzymol; 2020; 632():xxiii-xlii. PubMed ID: 32000917
    [No Abstract]   [Full Text] [Related]  

  • 9. A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism.
    Nelson B
    Cancer Cytopathol; 2014 Jan; 122(1):1-2. PubMed ID: 24424750
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy in anticancer responses.
    Whelan M
    Curr Opin Mol Ther; 2004 Feb; 6(1):8-9. PubMed ID: 15011775
    [No Abstract]   [Full Text] [Related]  

  • 11. How should clinical data be included in experimental studies of cancer immunology?
    Gjertsen BT; Bruserud Ø
    Cancer Immunol Immunother; 2004 Aug; 53(8):677-80. PubMed ID: 15069584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising immunotherapy technique.
    Fillon M
    J Natl Cancer Inst; 2012 Oct; 104(20):1528-9. PubMed ID: 23044382
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination strategies for enhancing the efficacy of immunotherapy in cancer patients.
    Moschella F; Proietti E; Capone I; Belardelli F
    Ann N Y Acad Sci; 2010 Apr; 1194():169-78. PubMed ID: 20536466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines and immunotherapeutics for the treatment of malignant disease.
    Aldrich JF; Lowe DB; Shearer MH; Winn RE; Jumper CA; Kennedy RC
    Clin Dev Immunol; 2010; 2010():697158. PubMed ID: 20936120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary immunotherapy of solid tumors: from tumor-associated antigens to combination treatments.
    Spagnoli GC; Ebrahimi M; Iezzi G; Mengus C; Zajac P
    Curr Opin Drug Discov Devel; 2010 Mar; 13(2):184-92. PubMed ID: 20205052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized Cancer Vaccines Advance in the Clinic.
    Schmidt C
    J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29095978
    [No Abstract]   [Full Text] [Related]  

  • 17. Current status and future perspectives of dendritic cell-based cancer immunotherapy.
    H Yi D; Appel S
    Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-13 receptor-directed cancer vaccines and immunotherapy.
    Nakashima H; Husain SR; Puri RK
    Immunotherapy; 2012 Apr; 4(4):443-51. PubMed ID: 22512637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA Technologies Expand Tool Kit for Cancer Immunotherapy.
    Cancer Discov; 2019 Oct; 9(10):OF5. PubMed ID: 31409586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
    Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
    Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.